crohns disease
Takeda, TiGenix Announce Phase III Trial Results For Crohn’s Disease Drug
A significantly greater proportion of patients in the treatment group versus the placebo group achieved combined remission at week 24.
Looking For Connections? Check The DNA ‘Phonebook’
Using a modified Capture Hi-C method, researchers have compile a comprehensive database of promoter interactions.
“Selfish” Gut Bacteria Steal From Yeast
Feeding the beneficial gut bacteria Bacteroides thetaiotaomicron could help alleviate inflammatory bowel disease.
New Risk Factor For Leukopenia In Asians Identified
A genetic variant of the NUDT15 gene could be used to screen Asian populations for sensitivity to thiopurine drugs.
